Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

NSAID use and clinical outcomes in COVID-19 patients: a 38-center retrospective cohort study
Justin Reese, Ben Coleman, Lauren Chan, et al.
Virology Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

The use of non-steroidal anti-inflammatory drugs (NSAIDs) in COVID-19
Pamela Kushner, Bill McCarberg, Laurent Grange, et al.
npj Primary Care Respiratory Medicine (2022) Vol. 32, Iss. 1
Open Access | Times Cited: 43
Risk factors for acute kidney injury in COVID-19 patients: an updated systematic review and meta-analysis
Jialing Zhang, Qi Pang, Ting Zhou, et al.
Renal Failure (2023) Vol. 45, Iss. 1
Open Access | Times Cited: 26
Predictive models of long COVID
Blessy Antony, Hannah Blau, Elena Casiraghi, et al.
EBioMedicine (2023) Vol. 96, pp. 104777-104777
Open Access | Times Cited: 22
COVID-19 and Rheumatoid Arthritis Crosstalk: Emerging Association, Therapeutic Options and Challenges
Saikat Dewanjee, Ramesh Kandimalla, Rajkumar Singh Kalra, et al.
Cells (2021) Vol. 10, Iss. 12, pp. 3291-3291
Open Access | Times Cited: 55
Ibuprofen, other NSAIDs and COVID-19: a narrative review
William Laughey, Imran Lodhi, Graham Pennick, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 5, pp. 2147-2159
Open Access | Times Cited: 17
Exploring the Pathophysiology of Long COVID: The Central Role of Low-Grade Inflammation and Multisystem Involvement
Evgeni Gusev, Alexey Sarapultsev
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6389-6389
Open Access | Times Cited: 7
Precision management of post‐COVID pain: An evidence and clinical‐based approach
César Fernández‐de‐las‐Peñas, Jo Nijs, Rocco Giordano, et al.
European Journal of Pain (2023) Vol. 27, Iss. 9, pp. 1107-1125
Open Access | Times Cited: 13
KG-Hub—building and exchanging biological knowledge graphs
J. Harry Caufield, Tim Putman, Kevin Schaper, et al.
Bioinformatics (2023) Vol. 39, Iss. 7
Open Access | Times Cited: 13
Evaluating NSAIDs in SARS-CoV-2: Immunomodulatory mechanisms and future therapeutic strategies
Said Moshawih, Qais Jarrar, Abdul Alim Bahrin, et al.
Heliyon (2024) Vol. 10, Iss. 3, pp. e25734-e25734
Open Access | Times Cited: 5
Headache, Loss of Smell, and Visual Disturbances: Symptoms of SARS-CoV-2 Infection? A Case Report
Filippo Maselli, Lorenzo Storari, Firas Mourad, et al.
Physical Therapy (2023) Vol. 103, Iss. 4
Open Access | Times Cited: 9
Liver Injury Associated with COVID-19 Infection: Pathogenesis, Histopathology, Prognosis, and Treatment
Noha Mousaad Elemam, Iman M. Talaat, Azzam A. Maghazachi, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 5, pp. 2067-2067
Open Access | Times Cited: 7
Effects of non‐steroidal anti‐inflammatory drugs and other eicosanoid pathway modifiers on antiviral and allergic responses: EAACI task force on eicosanoids consensus report in times of COVID‐19
Milena Sokołowska, G. Enrico Rovati, Zuzana Diamant, et al.
Allergy (2022) Vol. 77, Iss. 8, pp. 2337-2354
Open Access | Times Cited: 12
COVID-19—A Trigger Factor for Severe Immune-Mediated Thrombocytopenia in Active Rheumatoid Arthritis
Anca Bobircă, Florin Bobîrcă, I. Ancuta, et al.
Life (2022) Vol. 12, Iss. 1, pp. 77-77
Open Access | Times Cited: 10
Harnessing immunity: Immunomodulatory therapies in COVID-19
Tsvetelina Velikova, Hristo Valkov, A Aleksandrova, et al.
World Journal of Virology (2024) Vol. 13, Iss. 2
Open Access | Times Cited: 1
Ibuprofen in the Management of Viral Infections: The Lesson of COVID‐19 for Its Use in a Clinical Setting
Gianmarco Marcianò, Lucia Muraca, Vincenzo Rania, et al.
The Journal of Clinical Pharmacology (2023) Vol. 63, Iss. 9, pp. 975-992
Open Access | Times Cited: 3
Ramatroban for chemoprophylaxis and treatment of COVID-19: David takes on Goliath
Kate Chander Chiang, John G. Rizk, Deanna J. Nelson, et al.
Expert Opinion on Therapeutic Targets (2022) Vol. 26, Iss. 1, pp. 13-28
Open Access | Times Cited: 5
Effects of Antidepressants on COVID-19 Outcomes: Retrospective Study on Large-Scale Electronic Health Record Data
Md Mahmudur Rahman, Atqiya Munawara Mahi, Rachel Melamed, et al.
Interactive Journal of Medical Research (2023) Vol. 12, pp. e39455-e39455
Open Access | Times Cited: 2
Factores asociados con la mortalidad por SARS-CoV-2 en la población mayor de 75 años de la Comunidad de Madrid
José María Mostaza, M. A. Salinero-Fort, Juan Cárdenas‐Valladolid, et al.
Revista Clínica Española (2022) Vol. 222, Iss. 8, pp. 468-478
Open Access | Times Cited: 4
Factors associated with mortality due to SARS-CoV-2 in the population over 75 years of age in the Community of Madrid
José María Mostaza, Miguel Á. Salinero-Fort, Juan Cárdenas‐Valladolid, et al.
Revista Clínica Española (English Edition) (2022) Vol. 222, Iss. 8, pp. 468-478
Open Access | Times Cited: 3
Hypothesis: Efficacy of early treatments with some NSAIDs in COVID‐19: Might it also depend on their direct and/or indirect zinc chelating ability?
Loris Zamai
British Journal of Pharmacology (2022) Vol. 180, Iss. 3, pp. 279-286
Open Access | Times Cited: 3
Evaluation of quantitative bias analysis in epidemiological research: A systematic review from 2010 to mid‐2023
Kübra Elif Akbaş, Betül Dağoğlu Hark
Journal of Evaluation in Clinical Practice (2024) Vol. 30, Iss. 7, pp. 1413-1421
Closed Access
Application of TD-Based Unsupervised FE to Bioinformatics
Y‐h. Taguchi
Unsupervised and semi-supervised learning (2024), pp. 225-447
Closed Access
Association between long COVID and nonsteroidal anti-inflammatory drug use by patients with acute-phase COVID-19: A nationwide Korea National Health Insurance Service cohort study
Ye‐Seul Lee, Huijun Kim, Sunoh Kwon, et al.
PLoS ONE (2024) Vol. 19, Iss. 11, pp. e0312530-e0312530
Open Access
Effect of SARS-CoV-2 Infection on Renal and Hepatic Function after NSAID and Paracetamol Therapy
Aurélie Pahud de Mortanges, Evangelia Liakoni, Verena Schöning, et al.
COVID (2024) Vol. 4, Iss. 7, pp. 910-920
Open Access
Self-Prescribed Pharmacological Drugs Used for Covid-19 Prevention and Treatment in the Current Pandemic
Olalekan Fagbola
Texila international journal of public health (2022), pp. 179-199
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top